Literature DB >> 28693177

Low expression of microRNA-30c promotes prostate cancer cells invasion involved in downregulation of KRAS protein.

Jun Zhang1, Xilong Wang1, Yangyun Wang1, Ruixian Peng1, Zhiyuan Lin1, Yang Wang1, Bo Hu1, Jifeng Wang1, Guowei Shi1.   

Abstract

Aberrant microRNA expression is associated with tumor development. The present study aimed to elucidate the role of miR-30c in the development of prostate cancer. Quantitative polymerase chain reaction was performed to compare miR-30c expression in LNCaP, DU145, PC-3 and RWPE-1 cell lines. Lentivirus expressing miR-30c was used to create stable overexpression cell lines to investigate the effects of miR-30c overexpression on cell proliferation, migration and invasion, which were determined in the prostate cancer cell line PC-3 by MTT, colony formation, wound healing and Transwell assays. Effects of miR-30c on KRAS were examined by western blot analysis. miR-30c expression was significantly lower (P<0.05) in the PC-3 cell line compared with LNCaP, DU145 and RWPE-1 cell lines. miR-30c overexpression in PC-3 inhibited tumor cell proliferation, migration and invasion in vitro. Furthermore, KRAS protein expression was downregulated in miR-30c overexpression cell lines compared with the negative control (NC) group (P<0.05). The present results demonstrated that overexpression of miR-30c inhibits prostate cancer cell line proliferation, migration and invasion, which was possibly caused by downregulation of KRAS protein by miR-30c. The data implicate miR-30c in the prognosis and treatment of prostate cancer.

Entities:  

Keywords:  KRAS; invasion; microRNA-30c; prostate cancer

Year:  2017        PMID: 28693177      PMCID: PMC5494817          DOI: 10.3892/ol.2017.6163

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  25 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  MiR-146a suppresses tumor growth and progression by targeting EGFR pathway and in a p-ERK-dependent manner in castration-resistant prostate cancer.

Authors:  Bin Xu; Ning Wang; Xuhui Wang; Na Tong; Ning Shao; Jun Tao; Pengchao Li; Xiaobing Niu; Ninghan Feng; Lihua Zhang; Lixin Hua; Zengjun Wang; Ming Chen
Journal:  Prostate       Date:  2011-12-07       Impact factor: 4.104

3.  Low expression of microRNA-30c promotes invasion by inducing epithelial mesenchymal transition in non-small cell lung cancer.

Authors:  Zhaopeng Zhong; Yang Xia; Pengli Wang; Bin Liu; Yijiang Chen
Journal:  Mol Med Rep       Date:  2014-08-14       Impact factor: 2.952

4.  microRNA-30c negatively regulates endometrial cancer cells by targeting metastasis-associated gene-1.

Authors:  Huaijun Zhou; Xiaofeng Xu; Qingying Xun; Dongqi Yu; Jingxian Ling; Feifei Guo; Yuhua Yan; Jiayu Shi; Yali Hu
Journal:  Oncol Rep       Date:  2011-12-01       Impact factor: 3.906

5.  Combinations of serum prostate-specific antigen and plasma expression levels of let-7c, miR-30c, miR-141, and miR-375 as potential better diagnostic biomarkers for prostate cancer.

Authors:  Darina Kachakova; Atanaska Mitkova; Elenko Popov; Ivan Popov; Alexandrina Vlahova; Tihomir Dikov; Svetlana Christova; Vanio Mitev; Chavdar Slavov; Radka Kaneva
Journal:  DNA Cell Biol       Date:  2014-12-18       Impact factor: 3.311

6.  MicroRNA-30c expression level is an independent predictor of clinical benefit of endocrine therapy in advanced estrogen receptor positive breast cancer.

Authors:  F Germán Rodríguez-González; Anieta M Sieuwerts; Marcel Smid; Maxime P Look; Marion E Meijer-van Gelder; Vanja de Weerd; Stefan Sleijfer; John W M Martens; John A Foekens
Journal:  Breast Cancer Res Treat       Date:  2010-05-19       Impact factor: 4.872

7.  MicroRNA expression profiles classify human cancers.

Authors:  Jun Lu; Gad Getz; Eric A Miska; Ezequiel Alvarez-Saavedra; Justin Lamb; David Peck; Alejandro Sweet-Cordero; Benjamin L Ebert; Raymond H Mak; Adolfo A Ferrando; James R Downing; Tyler Jacks; H Robert Horvitz; Todd R Golub
Journal:  Nature       Date:  2005-06-09       Impact factor: 49.962

8.  miR-24 regulates apoptosis by targeting the open reading frame (ORF) region of FAF1 in cancer cells.

Authors:  Wenming Qin; Yi Shi; Botao Zhao; Chengguo Yao; Li Jin; Jiexian Ma; Youxin Jin
Journal:  PLoS One       Date:  2010-02-25       Impact factor: 3.240

9.  Isolinderalactone enhances the inhibition of SOCS3 on STAT3 activity by decreasing miR-30c in breast cancer.

Authors:  Meng-Chi Yen; Ying-Chu Shih; Ya-Ling Hsu; En-Shyh Lin; Yi-Shiuan Lin; Eing-Mei Tsai; Ya-Wen Ho; Ming-Feng Hou; Po-Lin Kuo
Journal:  Oncol Rep       Date:  2015-12-22       Impact factor: 3.906

10.  MicroRNA expression in ovarian carcinoma and its correlation with clinicopathological features.

Authors:  Heejeong Lee; Chul Soo Park; Georgios Deftereos; Janice Morihara; Joshua E Stern; Stephen E Hawes; Elizabeth Swisher; Nancy B Kiviat; Qinghua Feng
Journal:  World J Surg Oncol       Date:  2012-08-27       Impact factor: 2.754

View more
  8 in total

1.  Expression of miR-30c and miR-29b in prostate cancer and its diagnostic significance.

Authors:  Chuanan Zhu; Xiumei Hou; Jiabin Zhu; Chunxiao Jiang; Wei Wei
Journal:  Oncol Lett       Date:  2018-06-21       Impact factor: 2.967

2.  A Novel Predictor Tool of Biochemical Recurrence after Radical Prostatectomy Based on a Five-MicroRNA Tissue Signature.

Authors:  Zhongwei Zhao; Sabine Weickmann; Monika Jung; Michael Lein; Ergin Kilic; Carsten Stephan; Andreas Erbersdobler; Annika Fendler; Klaus Jung
Journal:  Cancers (Basel)       Date:  2019-10-21       Impact factor: 6.639

3.  Functional classification of prostate cancer‑associated miRNAs through CRISPR/Cas9‑mediated gene knockout.

Authors:  Fu-Neng Jiang; Yu-Xiang Liang; Wang Wei; Cui-Yun Zou; Guan-Xing Chen; Yue-Ping Wan; Ze-Zhen Liu; Yang Yang; Zhao-Dong Han; Jian-Guo Zhu; Wei-De Zhong
Journal:  Mol Med Rep       Date:  2020-09-07       Impact factor: 2.952

4.  miR-30c Impedes Glioblastoma Cell Proliferation and Migration by Targeting SOX9.

Authors:  Shihui Liu; Xiuxiu Li; Sujing Zhuang
Journal:  Oncol Res       Date:  2018-03-01       Impact factor: 5.574

5.  MicroRNA-212 Targets Mitogen-Activated Protein Kinase 1 to Inhibit Proliferation and Invasion of Prostate Cancer Cells.

Authors:  Bo Hu; Xunbo Jin; Jianbo Wang
Journal:  Oncol Res       Date:  2018-01-10       Impact factor: 5.574

6.  Retracted Article: Long non-coding RNA XIST promotes proliferation, autophagy and inhibits apoptosis by regulating microRNA-30c/ATG5 axis in gastric cancer.

Authors:  Mingjian Liu; Hongbo Zhao; Min Sheng; Hui Li
Journal:  RSC Adv       Date:  2018-11-07       Impact factor: 4.036

7.  MicroRNA-30e inhibits adhesion, migration, invasion and cell cycle progression of prostate cancer cells via inhibition of the activation of the MAPK signaling pathway by downregulating CHRM3.

Authors:  Xin-Min Zheng; Peng Zhang; Man-Hua Liu; Ping Chen; Wei-Bing Zhang
Journal:  Int J Oncol       Date:  2018-11-26       Impact factor: 5.650

8.  Identification of microRNA hsa-miR-30c-5p as an inhibitory factor in the progression of hepatocellular carcinoma and investigation of its regulatory network via comprehensive analysis.

Authors:  Shangshang Hu; Jinyan Zhang; Xiaoyu Fang; Guoqing Guo; Jing Dai; Zhiyong Sheng; Dongdong Li; Jiasheng Chen; Li Zhang; Chuanmiao Liu; Yu Gao
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.